Advertisement

Intraocular Pressure as a Risk Factor

  • Lina SiaudvytyteEmail author
Chapter

Abstract

Glaucoma is the leading cause of irreversible blindness worldwide. It remains a disease with an unclear and complex underlying pathophysiology. Intraocular pressure has been regarded as the main modifiable risk factor in the prevalence, incidence and progression of glaucoma. Chapter summaries the impact of intraocular pressure on glaucomatous optic neuropathy.

Keywords

Intraocular pressure Open-angle glaucoma 

References

  1. 1.
    Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA, et al. Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108(11):1943–53.CrossRefGoogle Scholar
  2. 2.
    Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol (Chicago, IL: 1960). 2002;120(6):701–30.CrossRefGoogle Scholar
  3. 3.
    Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol (Chicago, IL: 1960). 2003;121(1):48–56.CrossRefGoogle Scholar
  4. 4.
    Coleman AL, Caprioli J. The logic behind target intraocular pressure. Am J Ophthalmol. 2009;147:379–80.CrossRefGoogle Scholar
  5. 5.
    The Advanced Glaucoma Intervention Study (AGIS). The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol. 2000;130(4):429–40.CrossRefGoogle Scholar
  6. 6.
    Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998;126(4):487–97.CrossRefGoogle Scholar
  7. 7.
    Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol. 1998;126(4):498–505.CrossRefGoogle Scholar
  8. 8.
    Sommer A, Tielsch JM. Risk factors for open-angle glaucoma: the Barbados Eye Study. Arch Ophthalmol (Chicago, IL: 1960). 1996;114:235.CrossRefGoogle Scholar
  9. 9.
    Klein BE, Klein R, Linton KL. Intraocular pressure in an American community. The beaver dam eye study. Invest Ophthalmol Vis Sci. 1992;33(7):2224–8.PubMedGoogle Scholar
  10. 10.
    Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol (Chicago, IL: 1960). 1991;109(8):1090–5.CrossRefGoogle Scholar
  11. 11.
    Bonomi L, Marchini G, Marraffa M, Bernardi P, De Franco I, Perfetti S, et al. Prevalence of glaucoma and intraocular pressure distribution in a defined population. The Egna-Neumarkt Study. Ophthalmology. 1998;105(2):209–15.CrossRefGoogle Scholar
  12. 12.
    Guidelines E. European Glaucoma Society terminology and guidelines for Glaucoma, 4th edition—part 1. Br J Ophthalmol. 2017.Google Scholar
  13. 13.
    Mitchell P, Smith W, Attebo K, Healey PR. Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology. 1996;103(10):1661–9.CrossRefGoogle Scholar
  14. 14.
    Ramakrishnan R, Nirmalan PK, Krishnadas R, Thulasiraj RD, Tielsch JM, Katz J, et al. Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey. Ophthalmology. 2003;110(8):1484–90.CrossRefGoogle Scholar
  15. 15.
    Buhrmann RR, Quigley HA, Barron Y, West SK, Oliva MS, Mmbaga BB. Prevalence of glaucoma in a rural east African population. Invest Ophthalmol Vis Sci. 2000;41(1):40–8.PubMedGoogle Scholar
  16. 16.
    Burgoyne CF, Downs JC, Bellezza AJ, Suh J-KF, Hart RT. The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog Retin Eye Res. 2005;24(1):39–73.CrossRefGoogle Scholar
  17. 17.
    Heickell AG, Bellezza AJ, Thompson HW, Burgoyne CF. Optic disc surface compliance testing using confocal scanning laser tomography in the normal monkey eye. J Glaucoma. 2001;10(5):369–82.CrossRefGoogle Scholar
  18. 18.
    Yang H, Thompson H, Roberts MD, Sigal IA, Downs JC, Burgoyne CF. Deformation of the early glaucomatous monkey optic nerve head connective tissue after acute IOP elevation in 3-D histomorphometric reconstructions. Invest Ophthalmol Vis Sci. 2011;52(1):345–63.CrossRefGoogle Scholar
  19. 19.
    Tielsch JM, Katz J, Singh K, Quigley HA, Gottsch JD, Javitt J, et al. A population-based evaluation of glaucoma screening: the Baltimore Eye Survey. Am J Epidemiol. 1991;134(10):1102–10.CrossRefGoogle Scholar
  20. 20.
    Suzuki Y, Iwase A, Araie M, Yamamoto T, Abe H, Shirato S, et al. Risk factors for open-angle glaucoma in a Japanese population: the Tajimi study. Ophthalmology. 2006;113(9):1613–7.CrossRefGoogle Scholar
  21. 21.
    Leske MC, Wu S-Y, Hennis A, Honkanen R, Nemesure B. Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmology. 2008;115(1):85–93.CrossRefGoogle Scholar
  22. 22.
    Anderson DR, Drance SM, Schulzer M. Natural history of normal-tension glaucoma. Ophthalmology. 2001;108(2):247–53.CrossRefGoogle Scholar
  23. 23.
    Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol (Chicago, IL: 1960). 2002;120(10):1268–79.CrossRefGoogle Scholar
  24. 24.
    Musch DC, Gillespie BW, Niziol LM, Lichter PR, Varma R. Intraocular pressure control and long-term visual field loss in the collaborative initial Glaucoma treatment study. Ophthalmology. 2011;118(9):1766–73.CrossRefGoogle Scholar
  25. 25.
    Musch DC, Gillespie BW, Lichter PR, Niziol LM, Janz NK. Visual field progression in the collaborative initial Glaucoma treatment study the impact of treatment and other baseline factors. Ophthalmology. 2009;116(2):200–7.CrossRefGoogle Scholar
  26. 26.
    Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol (Chicago, IL: 1960). 2002;120(6):714–30.CrossRefGoogle Scholar
  27. 27.
    Miglior S, Zeyen T, Pfeiffer N, Cunha-Vaz J, Torri V, Adamsons I. Results of the European Glaucoma prevention study. Ophthalmology. 2005;112(3):366–75.CrossRefGoogle Scholar
  28. 28.
    Wallace J, Lovell HG. Glaucoma and intraocular pressure in Jamaica. Am J Ophthalmol. 1969;67(1):93–100.CrossRefGoogle Scholar
  29. 29.
    Sihota R, Saxena R, Gogoi M, Sood A, Gulati V, Pandey RM. A comparison of the circadian rhythm of intraocular pressure in primary phronic angle closure glaucoma, primary open angle glaucoma and normal eyes. Indian J Ophthalmol. 2005;53(4):243–7.CrossRefGoogle Scholar
  30. 30.
    Kim Y-K, Oh WH, Park KH, Kim JM, Kim DM. Circadian blood pressure and intraocular pressure patterns in normal tension glaucoma patients with undisturbed sleep. Korean J Ophthalmol. 2010;24(1):23–8.CrossRefGoogle Scholar
  31. 31.
    Asrani S, Zeimer R, Wilensky J, Gieser D, Vitale S, Lindenmuth K. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma. 2000;9(2):134–42.CrossRefGoogle Scholar
  32. 32.
    Liu JHK, Zhang X, Kripke DF, Weinreb RN. Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes. Invest Ophthalmol Vis Sci. 2003;44(4):1586–90.CrossRefGoogle Scholar
  33. 33.
    Gardiner SK, Johnson CA, Demirel S. Factors predicting the rate of functional progression in early and suspected glaucoma. Invest Ophthalmol Vis Sci. 2012;53(7):3598–604.CrossRefGoogle Scholar
  34. 34.
    Leidl MC, Choi CJ, Syed ZA, Melki SA. Intraocular pressure fluctuation and glaucoma progression: what do we know? Br J Ophthalmol. 2014;98(10):1315–9.CrossRefGoogle Scholar
  35. 35.
    Fukuchi T, Yoshino T, Sawada H, Seki M, Togano T, Tanaka T, et al. The relationship between the mean deviation slope and follow-up intraocular pressure in open-angle glaucoma patients. J Glaucoma. 2013;22(9):689–97.CrossRefGoogle Scholar
  36. 36.
    Medeiros FA, Weinreb RN, Zangwill LM, Alencar LM, Sample PA, Vasile C, et al. Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma. Ophthalmology. 2008;115(6):934–40.CrossRefGoogle Scholar
  37. 37.
    Nouri-Mahdavi K, Hoffman D, Coleman AL, Liu G, Li G, Gaasterland D, et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology. 2004;111(9):1627–35.CrossRefGoogle Scholar
  38. 38.
    Naito T, Yoshikawa K, Mizoue S, Nanno M, Kimura T, Suzumura H, et al. Relationship between progression of visual field defect and intraocular pressure in primary open-angle glaucoma. Clin Ophthalmol. 2015;9:1373–8.CrossRefGoogle Scholar
  39. 39.
    Bengtsson B, Leske MC, Hyman L, Heijl A. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology. 2007;114(2):205–9.CrossRefGoogle Scholar
  40. 40.
    Lee PP, Walt JW, Rosenblatt LC, Siegartel LR, Stern LS. Association between intraocular pressure variation and glaucoma progression: data from a United States chart review. Am J Ophthalmol. 2007;144(6):901–7.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Eye Clinic, Lithuanian University of Health SciencesKaunasLithuania

Personalised recommendations